McNally Beth A, O'Neil Edward J, Nguyen Anh, Smith Bradley D
Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.
J Am Chem Soc. 2008 Dec 24;130(51):17274-5. doi: 10.1021/ja8082363.
A new type of synthetic membrane transporter is described and shown to operate in vesicles by a relay mechanism. The transporter structure is a phosphatidylcholine derivative with a urea group appended to the end of its sn-2 acyl chain. The urea can bind a chloride ion at the membrane surface via hydrogen bonds and then relay it through the bilayer interior to an acceptor molecule located in the opposite membrane leaflet. Three phosphatidylcholine derivatives were studied and transport rates increased with transporter affinity for chloride. The results of various controls studies are consistent with an anion countertransport process using a relay mechanism and a kinetically active aggregate of two or four transporter molecules. Transport is inhibited if the transporter resides in only one leaflet of the membrane, if the bilayer is too thick, and if the counteranion is sulfate dianion. The expected favorable formulation properties of these amphiphilic compounds should facilitate efforts to transform them into tools for biomedical research and perhaps as therapeutic agents.
一种新型合成膜转运蛋白被描述并显示通过中继机制在囊泡中起作用。该转运蛋白结构是一种磷脂酰胆碱衍生物,在其sn-2酰基链末端连接有一个脲基。脲可以通过氢键在膜表面结合一个氯离子,然后将其通过双层内部传递到位于相对膜小叶中的受体分子。研究了三种磷脂酰胆碱衍生物,转运速率随转运蛋白对氯离子的亲和力增加而提高。各种对照研究的结果与使用中继机制和两个或四个转运蛋白分子的动力学活性聚集体的阴离子反向转运过程一致。如果转运蛋白仅存在于膜的一个小叶中、双层太厚以及抗衡阴离子为硫酸二价阴离子,则转运受到抑制。这些两亲性化合物预期的良好制剂性质应有助于将它们转化为生物医学研究工具甚至治疗剂的努力。